Yakira Capital Management, Inc. Merrimack Pharmaceuticals Inc Transaction History

Yakira Capital Management, Inc.

$197 Million
Q3 2024

Shares

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 14, 2024	BUY	$13.06 - $15.0 $870,292 - $999,570	66,638 Added 123.13%	120,756 $1.78 Million
Q3 2023 Nov 13, 2023	SELL	$11.6 - $12.52 $116,000 - $125,200	-10,000 Reduced 15.6%	54,118 $667,000
Q2 2023 Aug 11, 2023	SELL	$12.02 - $13.07 $96,160 - $104,560	-8,000 Reduced 11.09%	64,118 $788,000
Q1 2023 May 12, 2023	SELL	$11.35 - $12.32 $154,518 - $167,724	-13,614 Reduced 15.88%	72,118 $886,000
Q4 2022 Feb 10, 2023	SELL	$3.68 - $12.51 $110,727 - $376,413	-30,089 Reduced 25.98%	85,732 $982,000
Q2 2022 Aug 11, 2022	BUY	$4.89 - $7.13 $132,704 - $193,493	27,138 Added 30.6%	115,821 $689,000
Q1 2022 May 12, 2022	BUY	$3.75 - $6.82 $57,123 - $103,889	15,233 Added 20.74%	88,683 $561,000
Q4 2021 Feb 09, 2022	BUY	$3.75 - $5.1 $48,060 - $65,361	12,816 Added 21.14%	73,450 $287,000
Q4 2020 Feb 12, 2021	SELL	$3.69 - $8.31 $23,247 - $52,353	-6,300 Reduced 9.41%	60,634 $418,000
Q2 2018 Aug 13, 2018	SELL	$3.86 - $7.61 $28,950 - $57,075	-7,500 Reduced 10.08%	66,934 $329,000
Q1 2018 May 14, 2018	SELL	$6.24 - $9.15 $59,498 - $87,245	-9,535 Reduced 11.36%	74,434 $599,000
Q4 2017 Feb 13, 2018	BUY	$7.99 - $11.87 $547,810 - $813,830	68,562 Added 445.01%	83,969 $861,000
Q3 2017 Nov 14, 2017	BUY	$9.13 - $11.72 $140,665 - $180,570	15,407	15,407 $224,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yakira Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yakira Capital Management, Inc. with notifications on news.